See more : Swiss Water Decaffeinated Coffee Inc. (SWSSF) Income Statement Analysis – Financial Results
Complete financial analysis of Pharmaids Pharmaceuticals Limited (PHARMAID.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Pharmaids Pharmaceuticals Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- JS Corporation (194370.KS) Income Statement Analysis – Financial Results
- Jumbo Bag Limited (JUMBO.BO) Income Statement Analysis – Financial Results
- EV Resources Limited (EVR.AX) Income Statement Analysis – Financial Results
- Max Resource Corp. (MXROF) Income Statement Analysis – Financial Results
- Glory Sun Financial Group Limited (1282.HK) Income Statement Analysis – Financial Results
Pharmaids Pharmaceuticals Limited (PHARMAID.BO)
Industry: Medical - Pharmaceuticals
Sector: Healthcare
About Pharmaids Pharmaceuticals Limited
Pharmaids Pharmaceuticals Ltd. engages in the development, formulation, manufacture, and distribution of drugs. It manufactures generics, bulk drugs and intermediaries. The company was founded on March 1, 1989 and is headquartered in Hyderabad, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 145.97M | 0.00 | 39.39M | 85.51M | 0.00 | 5.61M | 4.49M | 12.03M | 16.84M | 17.30M | 14.05M | 12.75M | 12.35M | 7.84M | 5.10M | 4.21M | 4.66M |
| Cost of Revenue | 223.94M | 8.88M | 35.72M | 81.59M | 388.02K | 3.56M | 5.00M | 6.75M | 12.14M | 10.47M | 9.84M | 8.54M | 7.94M | 6.46M | 4.67M | 3.79M | 3.97M |
| Gross Profit | -77.97M | -8.88M | 3.68M | 3.92M | -388.02K | 2.05M | -510.70K | 5.27M | 4.71M | 6.83M | 4.21M | 4.20M | 4.42M | 1.38M | 434.00K | 420.00K | 689.00K |
| Gross Profit Ratio | -53.41% | 0.00% | 9.34% | 4.58% | 0.00% | 36.52% | -11.37% | 43.86% | 27.96% | 39.48% | 29.97% | 32.99% | 35.76% | 17.66% | 8.51% | 9.97% | 14.78% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 117.72K | 67.65K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 13.68M | 0.00 | 500.20K | 270.69K | 885.51K | 372.92K | 593.51K | 456.96K | 500.30K | 246.71K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 242.00K | 0.00 | 109.37K | 148.01K | 200.86K | 55.15K | 255.44K | 1.04M | 1.34M | 1.37M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 60.64M | 94.44M | 609.57K | 418.70K | 1.09M | 428.07K | 848.95K | 1.50M | 1.84M | 1.62M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 3.06M | -4.42M | 151.00K | 263.40K | -453.50K | 1.00K | -24.97K | 125.00 | 450.00K | 1.24M | 1.58M | 447.78K | 13.31K | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 16.98M | 90.15M | 2.40M | 3.19M | 3.69M | 3.13M | 3.36M | 6.11M | 9.13M | 9.12M | 9.37M | 4.19M | 3.82M | 3.05M | 1.46M | 1.22M | 1.51M |
| Cost & Expenses | 298.06M | 99.03M | 38.11M | 84.78M | 3.69M | 6.69M | 8.36M | 12.86M | 21.26M | 19.59M | 19.22M | 12.73M | 11.76M | 9.51M | 6.13M | 5.01M | 5.48M |
| Interest Income | 2.16M | 0.00 | -2.00 | 0.00 | 0.00 | 51.43K | 200.72K | 100.57K | 6.72K | 4.00K | 8.71K | 2.89K | 2.69K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 15.78M | 46.00K | 27.00K | 42.00 | 8.40K | 169.00 | 14.04K | 385.45K | 212.78K | 36.00 | 67.39K | 60.38K | 45.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 17.25M | 167.95K | 92.00K | 448.26K | 388.02K | 458.46K | 10.89K | 637.09K | 1.04M | 1.37M | 800.58K | 734.34K | 757.89K | 771.00K | 771.00K | 384.00K | 813.00K |
| EBITDA | -123.54M | -98.88M | 1.37M | 1.33M | -3.36M | -965.13K | -3.66M | 1.86M | -3.00M | 326.08K | -2.78M | 745.42K | 1.35M | -896.00K | -258.00K | -417.00K | -9.00K |
| EBITDA Ratio | -84.63% | 0.00% | 3.86% | 1.69% | 0.00% | -10.24% | -81.82% | -0.97% | -17.81% | 1.80% | -19.87% | 5.85% | 10.94% | -11.43% | -5.06% | -9.90% | -0.19% |
| Operating Income | -140.06M | -99.03M | 1.28M | 732.00K | -3.69M | -1.48M | -3.87M | -4.07M | -4.49M | -1.06M | -3.59M | 11.09K | 593.13K | -1.67M | -1.03M | -801.00K | -822.00K |
| Operating Income Ratio | -95.95% | 0.00% | 3.25% | 0.86% | 0.00% | -26.30% | -86.22% | -33.86% | -26.66% | -6.13% | -25.57% | 0.09% | 4.80% | -21.27% | -20.17% | -19.01% | -17.64% |
| Total Other Income/Expenses | -16.16M | -33.00K | 123.74K | 152.35K | -58.40K | -350.96K | 186.67K | 1.66M | 98.47K | -36.00 | -67.39K | 379.00K | -365.95K | 0.00 | 0.00 | 0.00 | -343.00K |
| Income Before Tax | -156.21M | -99.08M | 1.40M | 884.35K | -3.75M | -1.43M | -3.69M | 824.73K | -4.32M | -1.06M | -3.66M | 390.08K | 227.19K | -1.67M | -1.03M | -801.00K | -1.17M |
| Income Before Tax Ratio | -107.02% | 0.00% | 3.56% | 1.03% | 0.00% | -25.49% | -82.06% | 6.86% | -25.65% | -6.13% | -26.05% | 3.06% | 1.84% | -21.27% | -20.17% | -19.01% | -24.99% |
| Income Tax Expense | -37.78M | -23.52M | -49.00K | -48.76K | -4.09M | 343.16K | 171.65K | -272.16K | -345.47K | -405.42K | -117.49K | -120.67K | -141.65K | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -79.68M | -75.56M | 1.45M | 933.11K | 335.34K | -1.77M | -3.86M | 1.10M | -3.98M | -655.06K | -3.54M | 510.75K | 368.83K | -1.67M | -1.03M | -801.00K | -1.17M |
| Net Income Ratio | -54.59% | 0.00% | 3.68% | 1.09% | 0.00% | -31.60% | -85.88% | 9.12% | -23.60% | -3.79% | -25.21% | 4.01% | 2.99% | -21.27% | -20.17% | -19.01% | -24.99% |
| EPS | -3.71 | -5.86 | 0.14 | 0.09 | 0.03 | -0.17 | -1.13 | 0.32 | -1.17 | -0.19 | -1.04 | 0.15 | 0.11 | -0.51 | -0.31 | -0.24 | 0.00 |
| EPS Diluted | -3.71 | -5.86 | 0.14 | 0.09 | 0.03 | -0.17 | -1.13 | 0.32 | -1.17 | -0.19 | -1.04 | 0.15 | 0.11 | -0.51 | -0.31 | -0.24 | 0.00 |
| Weighted Avg Shares Out | 21.49M | 12.90M | 10.31M | 10.31M | 10.31M | 10.31M | 3.41M | 3.41M | 3.41M | 3.41M | 3.41M | 3.41M | 3.41M | 3.27M | 3.32M | 3.34M | 0.00 |
| Weighted Avg Shares Out (Dil) | 21.49M | 12.90M | 10.31M | 10.31M | 10.31M | 10.31M | 3.41M | 3.41M | 3.41M | 3.41M | 3.41M | 3.41M | 3.41M | 3.27M | 3.32M | 3.34M | 0.00 |
No news found for: PHARMAID.BO
Source: https://incomestatements.info
Category: Stock Reports